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Cadherin function: Breaking the barrier
Ken Ishii and Kathleen J. Green
Three desmoglein isoforms collaborate with
desmocollins to build the adhesive core of
desmosomes. A recent study has shown that altering
the ratio of desmoglein isoforms influences epidermal
barrier function, suggesting distinct roles for these
cadherins that extend beyond adhesion.
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The epidermis is a self-renewing, stratified epithelium
that serves as a first line of defense against the external
environment. Central to building this protective barrier are
intercellular junctions known as desmosomes, which are
present throughout the epidermis, but become more promi-
nent as cells differentiate and move into the outermost
layers of the skin. By anchoring the intermediate filament
cytoskeleton, which in this tissue is made up of keratins, to
sites of cell–cell adhesion, desmosomes form a highly
resilient, supracellular network which is required for tissue
integrity [1]. Desmosomes also participate in the construc-
tion of the cornified envelope, a protein–lipid polymer built
during the terminal phases of keratinocyte differentiation.
The inner layer of this tough, water-resistant shell is made
from crosslinked proteins in the keratinocyte cortex, among
which are desmosomal plaque components [2]. A recent
paper by Stanley and colleagues [3] suggests that we must
now consider a further expanded role for desmosomal
adhesion molecules. The evidence implicates desmogleins
in orchestrating differentiation-specific functions of the
most superficial layer of the epidermis, the stratum
corneum, and raises the provocative possibility that desmo-
somal cadherins are not simply intercellular glue.
Before delving into the data, a quick lesson in desmoso-
mology is called for. Desmosomes are highly organized
structures composed of members from three protein
families: the cadherins, armadillo proteins and plakins
(reviewed in [1]). The desmosomal cadherins can be
further subdivided into the desmocollins and desmogleins.
These transmembrane proteins interact with members of
the armadillo family, which in desmosomes includes plako-
globin and the plakophilins. The armadillo family members
bind in turn to desmoplakin, and possibly other members
of the plakin family of cytolinkers, which also includes
plectin, envoplakin and periplakin. Biochemical and cell
biological reconstitution studies suggest that intermediate
filaments are tethered to the desmosomal membrane
through a combination of linear and lateral protein interac-
tions, which form a three-dimensional meshwork subjacent
to the membrane, with each protein node making multiple
points of contact with neighboring proteins (Figure 1).
Complexity is further increased by the fact that desmo-
some structure and composition continually changes in a
gradient-like fashion as keratinocytes journey outward to
the skin’s surface. 
This dispatch will focus on one particular example of
desmosomal complexity: that exhibited by the transmem-
brane glycoproteins of desmosomes, the desmogleins (Dsgs)
and desmocollins (Dscs). Each desmosomal cadherin
subtype has three distinct isoforms, Dsg1–3 and Dsc1–3,
encoded by separate genes. Furthermore, each desmo-
collin has two products differing in the length of their
cytoplasmic domain, a longer ‘a’ form and a shorter ‘b’ form,
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The major components of desmosomes. This
simplified diagram shows representative
protein–protein interactions of desmosomal
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derived from alternative splicing. Dsg2 and Dsc2 are
detected in all desmosome-possessing tissues, including
simple epithelia such as the colon and small intestine, and
non-epithelial tissues such as myocardium and lymph node
follicles [4,5], whereas Dsc3, Dsg3, Dsc1 and Dsg1 are
restricted to stratified epithelial tissues [6,7]. In stratified
tissues, the desmosomal cadherins are typically expressed
in a differentiation-dependent pattern [7,8]. Central to the
work of Elias et al. [3] is the observation that, in the epi-
dermis, Dsg3 and Dsc3 are found in the deepest layers,
whereas Dsg1 and Dsc1 are found in the more differenti-
ated upper layers, while in contrast, in the oral mucous
membrane, both Dsg1 and Dsg3 are expressed throughout
all layers of the epithelium [9,10] (Figure 2).
On the basis of their similarity to the classic cadherins, it
was assumed that desmosomal cadherins mediate calcium-
dependent adhesion in keratinocytes. Several lines of evi-
dence are consistent with such a role. Antibodies to Dsg1
and Dsg3 are a common feature of patients with the auto-
immune disease pemphigus, in which blisters arise in
layers corresponding to the position of Dsg1 or Dsg3 in the
epidermis and/or oral cavity. The antibodies are causative
in the pathogenesis of pemphigus, as affinity-purified,
Dsg-specific antibodies from patients cause blisters when
passively transferred to mice [11]. Furthermore, Dsg3
knockout mice develop stress-induced blisters on oral
mucous membranes that resemble those observed in pem-
phigus patients [12]. Finally, in some systems, the expres-
sion of desmocollins and desmogleins together with
plakoglobin promotes adhesion in normally non-adherent
fibroblasts [13,14].
It is unclear whether, or to what extent, desmogleins can
substitute for each other functionally. Dsg1 would seem to
be sufficient for adhesion in superficial epidermis, as
blisters do not form in this region in Dsg3 null mice [12].
Furthermore, a recent study [15] showed that forced
expression of Dsg3 in transgenic mice prevents the blister
formation that normally occurs after passive transfer of anti-
Dsg1 antibodies from pemphigus foliaceus sera, suggesting
some overlap in adhesive function. It is also striking that
pemphigus foliaceus patients, whose antibodies inactivate
Dsg1, do not develop lesions in the mouth or vagina, even
though these regions experience mechanical stress, thus
suggesting that Dsg3 alone works perfectly well in adhesion
in these tissues. These observations raise a central question
in the field: if the desmogleins can compensate for each
other, why are there so many desmosomal cadherins? Is the
answer simply that the different desmosomal cadherin com-
binations mediate adhesive forces of varying strength,
appropriate for the degree of stress experienced in various
tissues and layers of complex tissues? Or are there other
functions of desmosomal cadherins beyond cell adhesion?
To begin to grapple with these questions in a physiologi-
cally relevant model, Elias et al. [3] engineered transgenic
mice in which the Dsg3 gene is expressed in all layers of
the skin, using the involucrin promoter. The distribution
of Dsg3, and the Dsg3:Dsg1 ratio, in the transgenic mice
more closely resembled that seen in the oral mucous mem-
brane than in the epidermis. Interestingly, transepidermal
permeability was affected in these mice, leading to death
shortly after birth as a result of severe dehydration. Histo-
logically, the epidermal stratum corneum exhibited a
compact lamellar pattern, similar to that seen in normal
oral mucous membrane and distinct from the so-called
‘basket-weave’ pattern of the skin. These observations all
suggest that the Dsg3:Dsg1 ratio in a complex epithelium
may regulate barrier structure and drive barrier function.
Electron microscopic analyses uncovered alterations in
desmosome ultrastructure in the transgenic mice that might
explain these histological changes. Normally, desmo-
somes in the nucleated layer are made of mirror image tri-
partite dense plaques with an electron-lucent center [16].
In the stratum corneum, the desmosomal adhesive core
is converted into an electron-dense intercellular structure
Figure 2
The distribution of Dsg1 and Dsg3 in the skin
and mucous membrane. In the skin, Dsg3 is
found in the deep basal and most immediate
suprabasal layers, whereas Dsg1 is found in
the more differentiated upper layers. In
contrast, in the oral mucous membrane, both
Dsg1 and Dsg3 are expressed throughout all
layers.
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or ‘plug’, accompanied by the disappearance of the plaque.
At this stage the desmosomes are called ‘corneodesmo-
somes’. In the epidermis, corneodesmosomes normally
persist until near the surface of the skin, where they degen-
erate, and the corneocytes slough off. In the Dsg3-express-
ing transgenic mice, premature desmosome dissolution was
observed by electron microscopy at the interface of stratum
granulosum and stratum corneum. This pattern of process-
ing is similar to that observed in normal oral mucous mem-
brane. Tape-stripping experiments confirmed that
adhesion of corneocytes was decreased in the transgenic
mice. Thus, loss of the barrier function in transgenic mice
correlated with early loss of corneocyte adhesion.
These results are provocative, as they are the first demon-
stration that altering the distribution of desmosomal cad-
herins isoforms affects the structure and function of the
epidermis. What might be the underlying basis by which
Dsg3 dictates barrier function and desquamation? Whole-
sale alteration of the genetic program of differentiation did
not appear to occur, as reproducible changes in several
markers including involucrin, loricrin, filaggrin and keratin
K10 were not observed. One formal possibility is that
Dsg3 and Dsg1 have different adhesive properties, some-
thing that is currently difficult to assess directly in a well-
defined experimental system. Assuming differences in
adhesive strength do contribute to premature corneodesmo-
some dissolution, the context in which Dsg3 is expressed
must play a critical role in determining how differences in
adhesion are converted into effects on the barrier, as junc-
tion dissolution does not normally occur in the basal layers
where Dsg3 is expressed.
Desquamation is thought to depend on the activity of pro-
teolytic and hydrolytic enzymes in the stratum corneum
[17,18]. Thus, it seems possible that the Dsg3:Dsg1 ratio
may affect desquamation by interfering with the normal
program of corneodesmosome proteolysis. For instance, if
Dsg3 were a substrate and more susceptible to proteolytic
degeneration than other adhesion receptors, altering the
Dsg isoform ratio could shift the balance of desmosomal
cadherin processing and accelerate desquamation. Dele-
tion of sequences in the extracellular adhesive domain
could result in loss of function, although one might predict
that Dsg1 should compensate for this loss. Desmoglein
processing would also generate an amino-terminally
deleted cytoplasmic tail domain, which could act in a dom-
inant negative fashion to disrupt desmosomes. This possi-
bility is consistent with a report that mice expressing
amino-terminally truncated Dsg3 exhibit abnormalities in
desmosomes and widening of intercellular spaces in the
basal layer of transgenic mouse epidermis [19].
It also seems possible that full-length, unprocessed Dsg3
might interfere with the normal adhesive architecture and
function by altering the stoichiometric relationships
among all desmosomal cadherins, including the ratio of
desmogleins to desmocollin partners. As there are differ-
ences in the repertoire and binding affinities of interaction
partners for the tails of different Dsg isoforms, altering
these cytoplasmic complexes could also regulate adhesive
strength in an ‘inside-out’ fashion. Consistent with the
importance of cellular context of desmoglein distribution,
recent work has shown that ectopically expressed Dsg1
disrupts desmosomes in certain cells, and cannot stably
incorporate into others that normally lack this isoform [20].
On the other hand, forced expression of equal or greater
amounts of Dsg2 did not interfere with its assembly into
desmosomes with endogenous Dsg2 [21]. Thus, outside of
its normal epidermal environment, Dsg3 may interfere
with normal desmosome structure, or itself be compro-
mised in its ability to incorporate into or function in
desmosomes. The possibility that this represents a normal
physiological mechanism for regulating desmosome pro-
cessing and barrier function in the oral cavity will require
further analysis.
It also seems possible that the presence of Dsg3 could
physically alter the localization and/or activity of enzymes
that process stratum corneum proteins. One might envi-
sion that it could do so through physical means, or through
alterations in intracellular signaling. Cadherin tails are
known to recruit a growing number of structural and regu-
latory binding partners, which govern both adhesive
strength and signaling [1,22]. In addition to members of
the armadillo family, cadherin tails and their associated
catenins recruit the EGF receptor, Fer, Shc, p120 and
tyrosine phosphatases. Although the primary binding part-
ners for desmosomal cadherins are the armadillo proteins
plakoglobin and plakophilins, and in some cases, plakins,
additional interaction partners are sure to be uncovered in
the future. Possible differences in identity, binding affin-
ity or stoichiometry of different desmosomal cadherins and
their cytoplasmic binding partners could affect the recruit-
ment and/or activity of enzyme complexes that in turn reg-
ulates substrate cleavage.
Another exciting, but speculative, possibility is that changes
in the desmosomal cadherin complex could impact on
nuclear functions in a differentiation-specific manner, pos-
sibly even the expression of proteases. Forced expression
of N-cadherin leads to increased production of the matrix
metalloproteinase MMP-9 in the response to growth factor
treatment in breast epithelial cells [23]. E-cadherin sup-
presses expression of MMP-2 in prostate cells [24], whereas
loss of E-cadherin-mediated adhesion increases matrix
metalloproteinase expression and activity [25]. Cadherins
have also been implicated in cell survival, cell growth,
neurite outgrowth, tumor cell motility and cell fate deter-
mination during embryogenesis [26]. Less is known about
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the role of desmosomal cadherins in signaling, although
the desmoglein binding protein plakoglobin has been
implicated in cell survival, growth and differentiation
[27–29]. Whatever the mechanism by which desmogleins
regulate epidermal barrier function, the new work by
Stanley and colleagues [3] promises to lead to a better
understanding of how desmosomal cadherins operate in
pathways that direct differentiation in complex tissues. 
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